A distinct consumer segment (about one-third of U.S. adults) identifies as actively trying to slow aging and accounts for the bulk of category spending and openness to novel treatments, while actual use of advanced in‑office treatments remains rare. This gap — high intent/awareness but low advanced adoption — positions 'aging preventers' as the gateway cohort that will determine how quickly new anti‑aging technologies and therapies scale.
— If anti‑aging demand is concentrated among an engaged minority, that shapes markets, regulation, health inequities, and the social meaning of aging as a status project.
2026.03.31
100% relevant
YouGov report: 35% call preventing aging important and 19% of that group spend >$50/month on anti‑aging products, while awareness of treatments (e.g., Botox 62% aware) far outstrips usage (3% used).
← Back to All Ideas